ID   PPM1B_RAT               Reviewed;         390 AA.
AC   P35815; Q546R0; Q64046;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   24-JUL-2024, entry version 160.
DE   RecName: Full=Protein phosphatase 1B;
DE            EC=3.1.3.16;
DE   AltName: Full=Protein phosphatase 2C isoform beta;
DE            Short=PP2C-beta;
GN   Name=Ppm1b; Synonyms=Pp2c2, Pppm1b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=1312947; DOI=10.1016/0014-5793(92)80344-g;
RA   Wenk J., Trompeter H.-I., Pettrich K.-G., Cohen P.T.W., Campbell D.G.,
RA   Mieskes G.;
RT   "Molecular cloning and primary structure of a protein phosphatase 2C
RT   isoform.";
RL   FEBS Lett. 297:135-138(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=7532404; DOI=10.1006/bbrc.1995.1245;
RA   Schafer K., Braun T.;
RT   "Monoclonal anti-FLAG antibodies react with a new isoform of rat Mg2+
RT   dependent protein phosphatase beta.";
RL   Biochem. Biophys. Res. Commun. 207:708-714(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Seroussi E., Shani N., Hayut A., Faier S., Ben-Meir D., Divinski I.,
RA   Smorodinsky N.I., Lavi S.;
RT   "Protein phosphatase 1B. Cloning and characterization of two major
RT   transcripts generated by alternative use of 3' exons.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Enzyme with a broad specificity. Dephosphorylates PRKAA1 and
CC       PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating
CC       it at 'Ser-172'. Plays an important role in the termination of TNF-
CC       alpha-mediated NF-kappa-B activation through dephosphorylating and
CC       inactivating IKBKB/IKKB (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Binds 2 magnesium or manganese ions per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Monomer. Interacts with PAK6. Interacts with the
CC       phosphorylated form of IKBKB/IKKB. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P36993}. Membrane
CC       {ECO:0000250|UniProtKB:P36993}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P36993}. Note=Weakly associates at the membrane
CC       and N-myristoylation mediates the membrane localization.
CC       {ECO:0000250|UniProtKB:P36993}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist. Isoforms appear to differ
CC         in their C-terminus.;
CC       Name=1; Synonyms=Beta-1;
CC         IsoId=P35815-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta-MPP;
CC         IsoId=P35815-2; Sequence=VSP_005093;
CC   -!- PTM: Isgylation negatively regulates its activity. {ECO:0000250}.
CC   -!- PTM: N-myristoylation is essential for the recognition of its
CC       substrates for dephosphorylation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PP2C family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S90449; AAB21898.1; -; mRNA.
DR   EMBL; S74572; AAB33430.1; -; mRNA.
DR   EMBL; AJ271837; CAC28067.1; -; mRNA.
DR   PIR; JC2524; JC2524.
DR   PIR; S20392; S20392.
DR   RefSeq; NP_149087.1; NM_033096.2. [P35815-1]
DR   AlphaFoldDB; P35815; -.
DR   SMR; P35815; -.
DR   BioGRID; 246799; 1.
DR   STRING; 10116.ENSRNOP00000074301; -.
DR   iPTMnet; P35815; -.
DR   PhosphoSitePlus; P35815; -.
DR   jPOST; P35815; -.
DR   PaxDb; 10116-ENSRNOP00000041472; -.
DR   Ensembl; ENSRNOT00055038977; ENSRNOP00055031648; ENSRNOG00055022700. [P35815-1]
DR   Ensembl; ENSRNOT00060007288; ENSRNOP00060005528; ENSRNOG00060004300. [P35815-1]
DR   Ensembl; ENSRNOT00065012514; ENSRNOP00065009212; ENSRNOG00065007932. [P35815-1]
DR   GeneID; 24667; -.
DR   KEGG; rno:24667; -.
DR   UCSC; RGD:3374; rat. [P35815-1]
DR   AGR; RGD:3374; -.
DR   CTD; 5495; -.
DR   RGD; 3374; Ppm1b.
DR   eggNOG; KOG0697; Eukaryota.
DR   HOGENOM; CLU_013173_4_0_1; -.
DR   InParanoid; P35815; -.
DR   OrthoDB; 11028at2759; -.
DR   Reactome; R-RNO-1169408; ISG15 antiviral mechanism.
DR   PRO; PR:P35815; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000030667; Expressed in skeletal muscle tissue and 20 other cell types or tissues.
DR   ExpressionAtlas; P35815; baseline and differential.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030145; F:manganese ion binding; IEA:InterPro.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; ISO:RGD.
DR   GO; GO:0006499; P:N-terminal protein myristoylation; ISS:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; ISS:UniProtKB.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; ISS:UniProtKB.
DR   GO; GO:1901223; P:negative regulation of non-canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   CDD; cd00143; PP2Cc; 1.
DR   Gene3D; 1.10.10.430; Phosphatase 2C, C-terminal domain suprefamily; 1.
DR   Gene3D; 3.60.40.10; PPM-type phosphatase domain; 1.
DR   InterPro; IPR015655; PP2C.
DR   InterPro; IPR000222; PP2C_BS.
DR   InterPro; IPR012911; PP2C_C.
DR   InterPro; IPR036580; PP2C_C_sf.
DR   InterPro; IPR036457; PPM-type-like_dom_sf.
DR   InterPro; IPR001932; PPM-type_phosphatase-like_dom.
DR   PANTHER; PTHR47992; PROTEIN PHOSPHATASE; 1.
DR   PANTHER; PTHR47992:SF105; PROTEIN PHOSPHATASE 1B; 1.
DR   Pfam; PF00481; PP2C; 1.
DR   Pfam; PF07830; PP2C_C; 1.
DR   SMART; SM00332; PP2Cc; 1.
DR   SUPFAM; SSF81606; PP2C-like; 1.
DR   SUPFAM; SSF81601; Protein serine/threonine phosphatase 2C, C-terminal domain; 1.
DR   PROSITE; PS01032; PPM_1; 1.
DR   PROSITE; PS51746; PPM_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cytoplasm; Hydrolase; Isopeptide bond; Lipoprotein;
KW   Magnesium; Manganese; Membrane; Metal-binding; Myristate; Phosphoprotein;
KW   Protein phosphatase; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O75688"
FT   CHAIN           2..390
FT                   /note="Protein phosphatase 1B"
FT                   /id="PRO_0000057748"
FT   DOMAIN          23..295
FT                   /note="PPM-type phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01082"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          371..390
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..16
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         60
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         60
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O75688"
FT   BINDING         61
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         243
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O75688"
FT   BINDING         286
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O75688"
FT   MOD_RES         386
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75688"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250|UniProtKB:O75688"
FT   CROSSLNK        12
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ISG15)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         379..390
FT                   /note="GAGDLEDSLVAL -> FYQPSTPYSDNVSYYEWQT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7532404"
FT                   /id="VSP_005093"
SQ   SEQUENCE   390 AA;  42889 MW;  D147615BC2FA140B CRC64;
     MGAFLDKPKT EKHNAHGAGN GLRYGLSSMQ GWRVEMEDAH TAVVGIPHGL EDWSFFAVYD
     GHAGSRVANY CSTHLLEHIT TNEDFRAADK SGFALEPSVE NVKTGIRTGF LKIDEYMRNF
     SDLRNGMDRS GSTAVGVMIS PTHIYFINCG DSRAVLCRNG QVCFSTQDHK PCNPMEKERI
     QNAGGSVMIQ RVNGSLAVSR ALGDYDYKCV DGKGPTEQLV SPEPEVYEIL RAEEDEFVVL
     ACDGIWDVMS NEELCEFVNS RLEVSDDLEN VCNWVVDTCL HKGSRDNMSI VLVCFANAPK
     VSDEAVKRDL ELDKHLESRV EEIMQKSGEE GMPDLAHVMR ILSAENIPNL PPGGGLAGKR
     NVIEAVYSRL NPNKDNDGGA GDLEDSLVAL
//
